Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
Tuesday, March 09, 2021Exelixis Inc and WuXi Biologics announced the companies have entered into an exclusive license agreement to support the continued expansion of Exelixis oncology biologics pipeline The agreement is the latest in a series of biologicsfocused transactio...
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
Monday, March 08, 2021Merck known as MSD outside the United States and Canada and Ridgeback Biotherapeutics LP announced preliminary results from Ridgebacks Phase a randomized doubleblind placebocontrolled trial to evaluate the safety tolerability
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide
Saturday, March 06, 2021ABclonal Biotechnology Co Ltd a global life science tools and services provider acquires Yurogen Biosystems LLC a contract research organization dedicated to monoclonal antibody discovery using singleBcellbased SMabTM platform to better serve researc...
ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases
Friday, March 05, 2021ConserV Bioscience Limited ConserV a clinicalstage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and eTheRNA immunotherapies NV eTheRNA a clinicalstage immunotherapy company focused...
ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
Friday, March 05, 2021ALX Oncology Holdings Inc a clinicalstage immunooncology company developing therapies that block the CD checkpoint pathway and Tallac Therapeutics Inc Tallac a privately held biopharmaceutical company harnessing the power of innate and adaptive immun...
Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
Thursday, March 04, 2021Tempest Therapeutics Inc a clinicalstage oncology company developing firstinclass therapeutics that combine both precision and immunemediated mechanisms today announced a clinical collaboration agreement with F HoffmannLa Roche Ltd
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya
Thursday, March 04, 2021Eisai Co Ltd announced today that it has decided to assent to and support a project led by CA Medlynks Kenya Ltd a subsidiary of the healthcare startup company engaged in improving healthcare access in Africa Connect Afya Co Ltd which aims to build a...
Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement
Thursday, March 04, 2021Vaxalto Biotherapeutics Inc wwwvaxaltocom a preclinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic viruses and Mount Sinai Innovation Partners MSIP
Iktos Announces Collaboration With Pfizer in AI for Drug Design
Wednesday, March 03, 2021Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer smallmolecule discovery programsOver the last few years phenomenal advances in AI algorithmic development and computational power have e...
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug
Wednesday, March 03, 2021Oscotec Inc the Korean drug development company and Beactica Therapeutics AB the Swedish drug discovery company announced a new research development and licensing agreement Oscotec and Beactica will initially jointly collaborate concerning research a...
